Literature DB >> 2769183

Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin.

H Gerlach1, H Lieberman, R Bach, G Godman, J Brett, D Stern.   

Abstract

Some in vivo observations have suggested that growing or perturbed endothelium, such as that which occurs during angiogenesis, is more sensitive to the action of cytokines (TNF/cachectin, TNF, or IL-1) than normal quiescent endothelial cells. This led us to examine the responsiveness of endothelium to TNF as a function of the growth/motile state of the cell. TNF-induced modulation of endothelial cell surface coagulant function was half-maximal at a concentration of approximately 0.1 nM in subconfluent cultures, whereas 1-2 nM was required for the same effect in postconfluent cultures. Perturbation of endothelial cell shape/cytoskeleton was similarly more sensitive to TNF in subconfluent cultures. Consistent with these results, radioligand binding studies demonstrated high affinity TNF binding sites, Kd approximately 0.1 nM on subconfluent cultures, whereas only lower affinity sites (Kd approximately 1.8 nM) were detected on postconfluent cultures. The mechanisms underlying this change in the affinity of endothelium for TNF were studied in four settings. Crosslinking experiments with 125I-TNF and endothelium showed additional bands corresponding to Mr approximately 66,000 and approximately 84,000 with subconfluent cultures that were not observed with postconfluent cultures. Experiments with X-irradiated endothelium, whose growth but not motility was blocked, indicated that proliferation was not required for induction of high affinity TNF sites. Postconfluent endothelium, triggered to enter the proliferative cycle by microbutuble poisons, expressed high affinity TNF binding sites together with changes in cell shape/cytoskeleton well before their entry into S phase. Using wounded postconfluent monolayers, cells that migrated into the wound and those close to the wound edge displayed enhanced TNF binding and modulation of coagulant properties. These results suggest a model for targetting TNF action within the vasculature; regulation of high affinity endothelial cell binding sites can direct TNF to activated cells in particular parts of the vascular tree.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769183      PMCID: PMC2189421          DOI: 10.1084/jem.170.3.913

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Protein iodination with solid state lactoperoxidase.

Authors:  G S David; R A Reisfeld
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture.

Authors:  P P Nawroth; D M Stern; W Kisiel; R Bach
Journal:  Thromb Res       Date:  1985-12-01       Impact factor: 3.944

4.  Immunization, isolation of immunoglobulins, estimation of antibody titre.

Authors:  N Harboe; A Ingild
Journal:  Scand J Immunol Suppl       Date:  1973

5.  The effect of bovine thrombomodulin on the specificity of bovine thrombin.

Authors:  H V Jakubowski; M D Kline; W G Owen
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

6.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

7.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.

Authors:  P P Nawroth; I Bank; D Handley; J Cassimeris; L Chess; D Stern
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

8.  Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S.

Authors:  D Stern; J Brett; K Harris; P Nawroth
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

9.  Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.

Authors:  J Brett; H Gerlach; P Nawroth; S Steinberg; G Godman; D Stern
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  20 in total

1.  [Infection-inflammation-sepsis: state of the art and future perspectives. Tübingen Intensive Symposium, 08.10.2005].

Authors:  F Schröder; W A Krueger
Journal:  Anaesthesist       Date:  2006-07       Impact factor: 1.041

Review 2.  Tumor necrosis factor regulation of major histocompatibility complex gene expression.

Authors:  D R Johnson; J S Pober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Alternative patterns of mitogenesis and cell scattering induced by acidic FGF as a function of cell density in a rat bladder carcinoma cell line.

Authors:  A M Vallés; G C Tucker; J P Thiery; B Boyer
Journal:  Cell Regul       Date:  1990-12

4.  Intracarotid recombinant human tumor necrosis factor-alpha reduces cerebral blood flow and methionine uptake in rat brain tumors.

Authors:  T Sasajima; K Mineura; M Kowada; J Hatazawa; S Miura
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

5.  Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.

Authors:  S H Murch; C P Braegger; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

6.  Endothelial tissue factor stimulation by proteinase 3 and elastase.

Authors:  M Haubitz; M Gerlach; H J Kruse; R Brunkhorst
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 7.  Combining radiotherapy and immunotherapy: a revived partnership.

Authors:  Sandra Demaria; Nina Bhardwaj; William H McBride; Silvia C Formenti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

8.  Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.

Authors:  G Archipoff; A Beretz; K Bartha; C Brisson; C de la Salle; C Froget-Léon; C Klein-Soyer; J P Cazenave
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

9.  Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester.

Authors:  G Archipoff; A Beretz; J M Freyssinet; C Klein-Soyer; C Brisson; J P Cazenave
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

10.  Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Authors:  M S Naylor; G W Stamp; W D Foulkes; D Eccles; F R Balkwill
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.